NasdaqCM - Nasdaq Real Time Price USD

Cyclacel Pharmaceuticals, Inc. (CYCCP)

5.60
+0.15
+(2.75%)
As of 10:52:35 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
14
43
420
0
0
Operating Expense
12,699
12,047
25,873
27,656
22,389
Operating Income
-12,685
-12,004
-25,453
-27,656
-22,389
Net Non Operating Interest Income Expense
16
12
266
210
16
Other Income Expense
4,894
-2
-364
1,531
188
Pretax Income
-7,775
-11,994
-25,551
-25,915
-22,185
Tax Provision
572
-782
-2,996
-4,717
-3,728
Net Income Common Stockholders
-8,347
-11,212
-22,756
-21,399
-18,658
Diluted NI Available to Com Stockholders
-8,347
-11,212
-22,756
-21,399
-18,658
Total Operating Income as Reported
-12,685
-12,004
-25,453
-27,656
-22,389
Total Expenses
12,699
12,047
25,873
27,656
22,389
Net Income from Continuing & Discontinued Operation
-8,347
-11,212
-22,555
-21,198
-18,457
Normalized Income
-12,205.36
-11,161.52
-22,189.54
-21,388.59
-18,493.61
Interest Income
16
12
266
210
16
Net Interest Income
16
12
266
210
16
EBIT
-12,685
-12,004
-25,453
-27,656
-22,389
EBITDA
-12,681
-11,998
-25,422
-27,624
-22,346
Reconciled Depreciation
4
6
31
32
43
Net Income from Continuing Operation Net Minority Interest
-8,347
-11,212
-22,555
-21,198
-18,457
Total Unusual Items Excluding Goodwill
4,884
-54
-414
233
44
Total Unusual Items
4,884
-54
-414
233
44
Normalized EBITDA
-17,565
-11,944
-25,008
-27,857
-22,390
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
1,025.64
-3.52
-48.54
42.41
7.39
12/31/2021 - 11/30/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

GNIIF GNI Group Ltd.
12.02
0.00%
 
PTCHF PureTech Health plc
1.6800
0.00%
 
SLNCF Silence Therapeutics plc
1.5000
0.00%
 
SBHMY Sino Biopharmaceutical Limited
9.48
0.00%
 
OPORF hVIVO plc
0.2400
0.00%
 
REVBW Revelation Biosciences, Inc.
0.0119
-0.83%
 
GNMSF Genmab A/S
224.30
0.00%
 
NTRBW Nutriband Inc.
2.0000
-10.31%
 
SBMFF Sino Biopharmaceutical Limited
0.7290
+15.71%
 
RKVTF RAKOVINA THERAPEUTICS INC
0.0476
+0.21%